|1|Prevalence and correlates of self-reported medication non-adherence among older adults with coronary heart disease, diabetes mellitus, and/or hypertension. (23291338)
Marcum Z.A.... Hanlon J.T.
|2|Atrophic cardiomyocyte signaling in hypertensive heart disease. (24084216)
Kamalov G.... Weber K.T.
|3|Markers of inflammation, endothelial activation, and arterial stiffness in hypertensive heart disease and the effects of treatment: results from the SILVHIA study. (24084214)
Jekell A.... Kahan T.
|4|Association between I^-blocker therapy and outcomes in patients hospitalised with acute exacerbations of chronic obstructive lung disease with underlying ischaemic heart disease, heart failure or hypertension. (22941975)
Stefan M.S.... Lindenauer P.K.
|5|Validation and psychometric properties of Chinese version of SF-36 in patients with hypertension, coronary heart diseases, chronic gastritis and peptic ulcer. (22994333)
Yang Z.... Wan C.
|6|Mechanisms of pulmonary hypertension related to ventricular septal defect in congenital heart disease. (22035778)
Pan X.... Ma K.
|7|Diltiazem in the treatment of hypertension and ischemic heart disease. (22059786)
|8|Fibrosis in hypertensive heart disease: molecular pathways and cardioprotective strategies. (20823713)
Shahbaz A.U.... Weber K.T.
|9|Autophagy in hypertensive heart disease. (20118246)
Wang Z.V.... Hill J.A.
|10|Platelet aggregation and endothelial function in patients with complicated essential hypertension (ischemic stroke) and coronary heart disease. (21113448)
Shimohina N.Y.... Tanashyan M.M.
|11|Distribution of left ventricular ejection fraction in patients with ischemic and hypertensive heart disease and chronic heart failure. (19892060)
Gaasch W.H.... Zile M.R.
|12|Cardioprotective effect of an L/N-type calcium channel blocker in patients with hypertensive heart disease. (19782264)
Kosaka T.... Ito H.
|13|Plasma lipid peroxidation and totalantioxidant status among dyslipidaemic and hypertensive Nigerians with high risk of coronary heart disease. (19761169)
Ogunro P.S.... Eziyi A.K.
|14|Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction. (19628115)
Borlaug B.A.... Redfield M.M.
|15|Enhanced detection of genetic association of hypertensive heart disease by analysis of latent phenotypes. (18435473)
Gu C.C.... DA!vila-RomA!n V.G.
|16|Diagnosis and treatment of myocardial fibrosis in hypertensive heart disease. (18772529)
|17|Effect of atorvastatin on endothelial function and inflammation in long-duration type 1 diabetic patients without coronary heart disease and arterial hypertension. (17941871)
Konduracka E.... Piwowarska W.
|18|Changes of the levels of adrenomedulin, endothelin-1 and nitric oxide in children with pulmonary hypertension secondary to congenital heart disease]. (18211765)
Chu M.P.... Ren Y.
|19|Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease. (17164490)
Engelfriet P.M.... Mulder B.J.
|20|Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. (17377073)
McCrindle B.W.... .
|21|Impaired apoptosis of pulmonary endothelial cells is associated with intimal proliferation and irreversibility of pulmonary hypertension in congenital heart disease. (17306711)
LAcvy M.... IsraAl-Biet D.
|22|Extracellular matrix remodeling in hypertensive heart disease. (16814654)
Shirwany A.... Weber K.T.
|23|Expression and pathological implication of transforming growth factor-beta1 mRNA and endothelin-1 mRNA in intraacinar pulmonary arterioles of congenital heart disease accompanied with pulmonary hypertension]. (15938827)
Gao B.H.... Wang Z.M.
|24|Apolipoprotein B100 as a risk factor of acute coronary syndrome and this risk factor effect on arterial hypertension in patients with ischemic heart disease]. (16281487)
Arabidze G.G.... Skriabina E.O.
|25|Hypertensive heart disease and fibrosis. (15218391)
Moncrieff J.... Dunn F.G.
|26|Quantification of D-dimer and soluble fibrin in blood plasma of people with ischemic heart disease and hypertension]. (16350758)
LugovskoA- E.V.... Komisarenko S.V.
|27|Calcium antagonists in the treatment of hypertension in patients with ischaemic heart disease. (12943483)
|28|Coronary heart disease, hypertension, and angiotensinogen gene variants in Indian population. (12938141)
Nair K.G.... Dalal J.J.
|29|Rationale of echocardiographic assessment of left ventricular wall stress and midwall mechanics in hypertensive heart disease. (12144838)
De Simone G.... Devereux R.B.
|30|Behavioral treatment of hypertensive heart disease in African Americans: rationale and design of a randomized controlled trial. (11763829)
Schneider R.H.... Nidich S.
|31|Other diseases with diastolic dysfunction: how to deal with? Hypertensive heart disease. (10582462)
|32|Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: the Barilla factory revisited. (10459563)
Zavaroni I.... Reaven G.M.
|33|The relationship between angiotensin II type 1 receptor gene and coronary heart disease, hypertension and diabetes mellitus in Chinese]. (9456365)
Xiang K.... Li J.
|34|Hypertensive heart disease syndrome in women in a cardiology practice. (9283740)
Katholi R.E.... Ginsburg G.
|35|A symposium: progress in hypertensive heart disease: microangiopathy, molecular and cellular biology, cardiac arrhythmias, and heart failure. February 23-24, 1995, Bilbao, Spain. Proceedings. (7495210) |1995|
|36|Progressive intraventricular drop of early diastolic flow velocity reflects impaired active ventricular diastolic function in hypertensive heart disease: comparative study between early diastolic and atrial contraction phases. (9417208)
Yamamoto K.... Kamada T.
|37|Correction of left ventricular ischemia in blacks with hypertensive heart disease. (8398011)
Carr A.A.... Houghton J.L.
|38|Renin-angiotensin system and myocardial collagen matrix remodeling in hypertensive heart disease: in vivo and in vitro studies on collagen matrix regulation. (8518539)
Brilla C.G.... Weber K.T.
|39|Functional and organic components of diastolic dysfunction in hypertensive heart disease: therapeutic implications. (8281953)
Sagastagoitia D.... Iriarte M.
|40|Coronary haemodynamics in hypertensive heart disease. (1396859)
Vogt M.... Strauer B.E.
|41|Isolated myocardial cells: a new tool for the investigation of hypertensive heart disease. (2147954)
Neyses L.... Vetter H.
|42|Effects of antihypertensive therapy on hypertensive heart disease. (2532079)
Messerli F.H.... Losem C.J.
|43|Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease. (2962004)
|44|Hypertensive heart disease and endocardially recorded late potentials. (2485017)
Bethge C.... Strauer B.E.
|45|Ischemic and hypertensive heart disease in the aged: prognostic and therapeutic factors. (7410762)
|46|Hypertensive heart disease and cardiomyopathy in blacks. Diagnostic confusion. (451782)
|47|Pathophysiology and biochemistry of end-stage hypertensive heart disease. (4286892)
|48|Biochemical versus hemodynamic factors in the origin of hypertensive heart disease. (15432146)
RAAB W.... LEPESCHKIN E.
|50|The reversibility of hypertensive heart disease by lumbodorsal sympathectomy. (20277847)